These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6029134)

  • 21. [Epidemiologic analysis of mumps virus infections in the City of Warsaw in the years 1972-1973].
    Zabicka J; Imbs D; Czachorowska M
    Przegl Epidemiol; 1974; 28(4):425-32. PubMed ID: 4445520
    [No Abstract]   [Full Text] [Related]  

  • 22. Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I.
    Otten A; Helmke K; Stief T; Mueller-Eckhard G; Willems WR; Federlin K
    Behring Inst Mitt; 1984 Jul; (75):83-8. PubMed ID: 6385957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mumps vaccination].
    Cantell K; Penttinen K
    Duodecim; 1968; 84(16):909-11. PubMed ID: 5706112
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vaccination against epidemic parotitis].
    Midulla M; Chiavelli S
    Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of vaccination with Czechoslovakian vaccine against parotitis].
    Plesník V; Fedová D; Sejda J; Slonim D; Cervenka P; Walderová O; Marten J; Casný J; Dolezalová D
    Cesk Pediatr; 1984 Sep; 39(9):540-6. PubMed ID: 6509646
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on mumps antibodies in saliva with mumps patients].
    Chiba Y
    Sapporo Igaku Zasshi; 1970; 35(3):137-48. PubMed ID: 5535653
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccines: more reasons to immunize.
    Consum Rep; 2006 Oct; 71(10):62. PubMed ID: 16981311
    [No Abstract]   [Full Text] [Related]  

  • 28. [Wide-spread inflammation of the parotid glands (mumps): an underestimated disease. II. Development, use, efficacy and safety of mumps vaccines].
    Gałazka A; Kraigher A; Robertson SE
    Przegl Epidemiol; 1998; 52(4):401-12. PubMed ID: 10321084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mumps vaccine: rationale for its use.
    Andelman MB
    GP; 1969 Nov; 40(5):119-23. PubMed ID: 5356629
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibodies against the mumps virus in children and adults. An infestation study].
    Goetz O; Peller P
    Monatsschr Kinderheilkd (1902); 1978 May; 126(5):244-5. PubMed ID: 651905
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of live attenuated S79 mumps vaccine effectiveness in mumps outbreaks: a matched case-control study.
    Fu CX; Nie J; Liang JH; Wang M
    Chin Med J (Engl); 2009 Feb; 122(3):307-10. PubMed ID: 19236809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vaccination against mumps successful].
    Hirasing RA; Schaapveld K
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1498-500. PubMed ID: 8366936
    [No Abstract]   [Full Text] [Related]  

  • 33. [Epidemics in vaccinated persons. Do adults need a mumps booster vaccination? (interview by Dr. Judith Neumaier)].
    Mankertz A
    MMW Fortschr Med; 2008 Jun; 150(23):7. PubMed ID: 18578069
    [No Abstract]   [Full Text] [Related]  

  • 34. Is the severity of mumps related to the number of doses of mumps-containing vaccine?
    Borchardt SM; Rao P; Dworkin MS
    Clin Infect Dis; 2007 Oct; 45(7):939-40. PubMed ID: 17806066
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of study of live antiparotitic vaccine and perspectives for the elimination of mumps as a mass infection.
    Kliachko NS; Shaposhnikova RP; Martysheva LN
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(1):45-54. PubMed ID: 6070334
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serological and epidemological data on associated vaccines against measles and mumps].
    Shikina ES; Taros LIu; Tregubova TV; Matiushina NV; Luzianina TIa; Mikutskaia BA; Nasibov MN; Smorodintsev AA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():291-300. PubMed ID: 5860949
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immune structure of the pediatric population in relation to the mumps virus and the morbidity of serous meningitis of mumps etiology in Sverdlovsk].
    Venediktova NIa; Kolpakova VE; Kozlova SN; Zakirova SF; Lavrinova RV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Nov; (11):31-4. PubMed ID: 2948352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Re-emergence of acute lymphocytic meningitis caused by mumps virus in Spain].
    Echevarría JM; de Ory F; Echevarría C; Lozano A; Tenorio A
    Enferm Infecc Microbiol Clin; 1999; 17(7):373-4. PubMed ID: 10535201
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)].
    Chamot E; Toscani L; Egger P; Germann D; Bourquin C
    Rev Epidemiol Sante Publique; 1998 Mar; 46(2):100-7. PubMed ID: 9592852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.